The Supreme Court will begin its 2014-2015 term next Monday. Last year, the Court heard a record number of patent law cases, at least for recent history. Nevertheless, it is scheduled to hear another one on October 15. Teva Pharmaceuticals USA, Inc. JD Supra, 16 hours ago
Supreme IP: the U.S. Supreme Court weighs in on IP rights - Lexology, 1 day ago
Supreme Court corner - September, 2014 - Lexology, 2 weeks ago
1 images for "sandoz inc"
at 6.20 p.m. EEST Orion Corporation ("Orion") together with Hospira, Inc. ("Hospira") and Sandoz Inc. and Sandoz Canada Inc. (hereinafter collectively "Sandoz") have amended the settlement agreement published on 5 December 2013 regarding the market ...Individual.com, 1 week ago REG-Orion announces amended settlement agreement over the proprietary drug Precedex(R) Reuters, 1 week ago
More from: Stock Nod, Stock Nod...and 64 other sources
PLAINSBORO — The former home of Novo Nordisk, a Danish pharmaceutical company that has sat vacant along Route 1 for more than a year, will soon have a new tenant and new job opportunities. Sandoz Inc., a major pharmaceutical company that ...BioSpace, 1 day ago
Novartis : CONTRACT AWARD - 65-- Oxazepam Capsules Sandoz, Inc Effective: 9/22/2014 - 9/21/2015 (+ 4 one year options)
Notice Type: CONTRACT AWARD Posted Date: 12-SEP-14 Office: VA National Acquisition Center Location: DEPARTMENT OF VETERANS AFFAIRS NATIONAL ACQUISITION CENTER Office Address: DEPARTMENT OF VETERANS AFFAIRS , VA NATIONAL ACQUISITION ...4 Traders, 2 weeks ago
SAN DIEGO, Oct. 1, 2014 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines to meet the needs of patients, today announced that Richard Pascoe, Chief Executive Officer, will present ...TheStreet.com, 34 minutes ago APRICUS BIOSCIENCES : to Present at the 13th Annual BIO Investor Forum 4 Traders, 29 minutes ago
PharmaDerm, a dermatology business of Sandoz, has launched KERYDIN topical solution, 5%, for the treatment of onychomycosis of the toenails, in US. KERYDIN is developed by Anacor Pharmaceuticals, Inc. In July 2014, Sandoz announced an agreement with ...Individual.com, 4 days ago Anacor's Kerydin Launched in the US for Onychomycosis Yahoo! Finance, 1 week ago Anacor Announces U.S. Launch Of KERYDIN Topical Solution, 5% RTTNews.com, 1 week ago
STATE COURT CASES BUSINESS ENTITIES 12-2-5235 Seven Caesars, Inc. v. Dooley House, App. Div. (per curiam) (31 pp.) The question before the court is whether a foreign corporation whose certificate of authority to conduct business in New Jersey ...New Jersey Law Journal, 1 week ago
Allergan Inc. In a notice published on its website Sept. 12, the court rejected a petition to reconsider its June invalidation of their patents. The rulings clear the way for generic versions of Latisse to enter the market. In June, the Federal ...BusinessWeek, 2 weeks ago
Rheumatic heart disease (RHD) is a silent killer that is still prevalent in developing countries. A new study by the Novartis Institutes for BioMedical Research (NIBR), which uses Sandoz-donated, life-saving penicillin, aims to address RHD among ...Biz Community, 3 weeks ago Novartis : Sandoz donates penicillin for Rheumatic Heart Disease research 4 Traders, 3 weeks ago
CHICAGO--(BUSINESS WIRE)-- Fitch Ratings has affirmed the ratings for Amgen Inc. (Amgen) including Amgen's 'BBB'/'F2' Issuer Default Rating (IDR). The Rating Outlook remains Negative. A full list of rating actions follows at the end of this press ...CNBC, 3 weeks ago
on your WebpageAdd Widget >Get your members hooked!